Healthcare Innovation January 6, 2023
Geert De Lombaerde

The pharmacy giant’s leaders say their healthcare services group should produce about $7 billion in sales this year.

On the heels of an M&A binge since the fall of 2021, Walgreens Boots Alliance’s moves to further grow its healthcare services lineup will be more tactical in the quarters ahead, CFO James Kehoe said Jan. 5.

“We’re taking a pause. We need to focus on integration activities,” Kehoe said on a conference call discussing Walgreen’s results for the three months ended Nov. 30. “We’re not going to go out and do a $2 billion or $3 billion acquisition of a health tech company. We’re likely to be very targeted, and it will be in the hundreds of millions, not in the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Post-Acute Care, Primary care, Provider, Specialist care, Trends
MSD opens $1bn plant for HPV vaccine in the US
AI Superintelligence Startup Promises New Drug Discoveries
STAT+: Roche partners with Zealand Pharma to push forward obesity drug
Trends Shaping Direct to Patient in Pharma: Q&A with Scott Snyder
4 Prescription Drug Trends that are Top of Mind for One Abarca Exec

Share This Article